Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

AIM: To compare the effectiveness of sequential therapy for Helicobacter pylori (H. pylori) infection with that of triple therapy of varying durations. METHODS: The 460 patients enrolled in this study had H. pylori-associated gastritis or a gastric or duodenal ulcer. After screening, H. pylori-infected patients were randomly assigned to receive either conventional triple therapy for 7, 10 or 14 d, or a new 10-d sequential therapy. Each of the 4 treatment groups included 115 patients. The outcomes of eradication therapy were assessed 4 wk after treatment by the urea breath test and histology. RESULTS: The overall eradication rate was 81.0%, and eradication rates were 75.7% for 7-d conventional triple therapy, 81.9% for 10-d conventional triple therapy, 84.4% for 14-d conventional triple therapy, and 82.0% for 10-d sequential therapy. Neither intention-to-treat analysis nor per protocol analysis showed significant differences in eradication rates using sequential therapy or the standard triple therapy (P = 0.416 and P = 0.405, respectively). CONCLUSION: There are no significant differences between 10-d sequential eradication therapy for H. pylori and any duration of standard triple treatment in Korean patients.

Original languageEnglish
Pages (from-to)2377-2382
Number of pages6
JournalWorld Journal of Gastroenterology
Volume18
Issue number19
DOIs
Publication statusPublished - 2012 May 21

Keywords

  • Duodenal ulcer
  • Gastric ulcer
  • Gastritis
  • Helicobacter pylori
  • Sequential therapy
  • Triple therapy

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection'. Together they form a unique fingerprint.

  • Cite this